These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19637106)

  • 1. Third trimester fetoscopic laser ablation of type II vasa previa.
    Chmait RH; Chavira E; Kontopoulos EV; Quintero RA
    J Matern Fetal Neonatal Med; 2010 May; 23(5):459-62. PubMed ID: 19637106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-trimester fetoscopic ablation therapy for types II and III vasa previa.
    Chmait RH; Monson MA; Chon AH; Masri J; Korst LM; Incerpi MH
    Am J Obstet Gynecol; 2024 Jan; 230(1):87.e1-87.e9. PubMed ID: 37741533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Term vaginal delivery following fetoscopic laser photocoagulation of type II vasa previa.
    Johnston R; Shrivastava VK; Chmait RH
    Fetal Diagn Ther; 2014; 35(1):62-4. PubMed ID: 24246791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetoscopic Laser Ablation Therapy for Type II Vasa Previa.
    Chmait RH; Catanzarite V; Chon AH; Korst LM; Llanes A; Ouzounian JG
    Fetal Diagn Ther; 2020; 47(9):682-688. PubMed ID: 32629451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetoscopic Laser Ablation of Type II Vasa Previa: A Cost Benefit Analysis.
    Monson MA; Chmait RH; Einerson B
    Am J Perinatol; 2024 May; 41(S 01):e2454-e2462. PubMed ID: 37494587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero laser treatment of type II vasa previa.
    Quintero RA; Kontopoulos EV; Bornick PW; Allen MH
    J Matern Fetal Neonatal Med; 2007 Dec; 20(12):847-51. PubMed ID: 18050017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetoscopic laser ablation of vasa previa in pregnancy complicated by giant fetal cervical lymphatic malformation.
    Hosseinzadeh P; Shamshirsaz AA; Cass DL; Espinoza J; Lee W; Salmanian B; Ruano R; Belfort MA
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):507-8. PubMed ID: 25612246
    [No Abstract]   [Full Text] [Related]  

  • 8. Fetoscopic laser ablation in pregnancies with Type-II vasa previa.
    Papanna R; Agarwal N; Bergh EP; Brock C; Espinoza J; Johnson A
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):779-781. PubMed ID: 36609872
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetoscopic laser therapy for twin-twin transfusion syndrome before 17 and after 26 weeks' gestation.
    Baud D; Windrim R; Keunen J; Kelly EN; Shah P; van Mieghem T; Seaward PG; Ryan G
    Am J Obstet Gynecol; 2013 Mar; 208(3):197.e1-7. PubMed ID: 23178244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for fetoscopic laser ablation therapy in Type-2 vasa previa?
    Ibirogba ER; Shazly SA; Chmait RH; Ruano R
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):696. PubMed ID: 30801796
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasa previa: diagnosis and management.
    Swank ML; Garite TJ; Maurel K; Das A; Perlow JH; Combs CA; Fishman S; Vanderhoeven J; Nageotte M; Bush M; Lewis D;
    Am J Obstet Gynecol; 2016 Aug; 215(2):223.e1-6. PubMed ID: 26944186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of stillbirth: impact of two-stage screening for vasa previa.
    Zhang W; Geris S; Beta J; Ramadan G; Nicolaides KH; Akolekar R
    Ultrasound Obstet Gynecol; 2020 May; 55(5):605-612. PubMed ID: 31840871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis and management of vasa previa: a 6-year review.
    Kanda E; Matsuda Y; Kamitomo M; Maeda T; Mihara K; Hatae M
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1391-6. PubMed ID: 21599804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome.
    Lee W; Lee VL; Kirk JS; Sloan CT; Smith RS; Comstock CH
    Obstet Gynecol; 2000 Apr; 95(4):572-6. PubMed ID: 10725492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rate of Cervical Length Shortening in the Management of Vasa Previa.
    Maymon R; Melcer Y; Tovbin J; Pekar-Zlotin M; Smorgick N; Jauniaux E
    J Ultrasound Med; 2018 Mar; 37(3):717-723. PubMed ID: 28880409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatally Diagnosed Vasa Previa: A Single-Institution Series of 96 Cases.
    Catanzarite V; Cousins L; Daneshmand S; Schwendemann W; Casele H; Adamczak J; Tith T; Patel A
    Obstet Gynecol; 2016 Nov; 128(5):1153-1161. PubMed ID: 27741189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double fatal outcome after ruptured vasa previa in monochorionic twins: case report and review of the literature.
    van Steenis A; Zhao DP; Steggerda SJ; Kist WJ; Haak MC; Oepkes D; Lopriore E
    J Matern Fetal Neonatal Med; 2016; 29(15):2523-6. PubMed ID: 26366672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. #37: Diagnosis and management of vasa previa.
    ; Sinkey RG; Odibo AO; Dashe JS
    Am J Obstet Gynecol; 2015 Nov; 213(5):615-9. PubMed ID: 26292048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of risk for vasa previa at 9-13 weeks' gestation.
    Hasegawa J; Nakamura M; Sekizawa A; Matsuoka R; Ichizuka K; Okai T
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1346-51. PubMed ID: 21564407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report of vasa previa incidentally discovered.
    Saghir S; Kouach J; Agadr A
    Pan Afr Med J; 2015; 21():34. PubMed ID: 26405470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.